Immunologic Research

, Volume 65, Issue 1, pp 66–71 | Cite as

Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)

  • Osamu Hotta
  • Ayaki Tanaka
  • Akira Torigoe
  • Kazuaki Imai
  • Norio Ieiri
  • on behalf of the Japanese Focal Inflammation Research Group
Environment and Autoimmunity

Abstract

The epipharynx is an immunologically active site even under normal conditions, and enhanced immunologic activation is prone to occur in response to an upper respiratory infection, air pollution, and possibly to vaccine adjuvants. Due to the potential link between the central nervous system and immune function, a relationship between epipharyngitis and autonomic nervous disturbance as well as autoimmune disease has been suggested. Various functional somatic symptoms have been described after human papillomavirus (HPV) vaccination, although a causal relationship has not been established. We examined the epipharynx in young women showing functional somatic symptoms following HPV vaccination. Surprisingly, despite having minimal symptoms involving the pharynx, all patients were found to have severe epipharyngitis. In addition, significant improvement in symptoms was seen in most patients who underwent epipharyngeal treatment. Thus, we speculate that the chronic epipharyngitis potentially caused by the vaccine adjuvant may be involved in the pathogenesis of functional somatic syndrome (FSS) post-HPV vaccination. Further, we suggest that epipharyngeal treatment may be effective for various types of FSS regardless of the initial cause, as well as for some autoimmune diseases, and that this may be an important direction in future research.

Keywords

Chronic epipharyngitis Functional somatic syndrome Human papillomavirus vaccine Adjuvant 

Abbreviations

HPV

Human papillomavirus

FSS

Functional somatic syndrome

HPA

Hypothalamic–pituitary–adrenal

ASIA

Autoimmune/inflammatory syndrome induced by adjuvant

Notes

Acknowledgments

We thank Professors Kensuke Joh and Prof. Yehuda Shoenfeld for their encouragement. We also appreciate Dr. Yoshiteru Aida and Mr. Tatsushi Ohsawa for their contribution to this research.

Compliance with ethical standards

Conflict of interest

Osamu Hotta, Ayaki Tanaka, Akira Torigoe, Kazuaki Imai, and Norio Ieiri declare that they have no conflict of interest in this work.

References

  1. 1.
    Horiguchi S. The discovery of the nasopharyngitis and its influence on general diseases. Acta Otolaryngol Suppl. 1975;329:1–120.CrossRefGoogle Scholar
  2. 2.
    WHO. Human papillomavirus vaccines: WHO position paper. Biologicals. 2009;37:338–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Fesefeld M, Hutubessy R, Jit M. Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systemic review. Vaccine. 2013;31:3786–804.CrossRefGoogle Scholar
  4. 4.
    Kinoshita T, Abe RT, Hineno A, Tsunekawa K, Nakane S, Ikeda S. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med. 2014;53:2185–200.CrossRefPubMedGoogle Scholar
  5. 5.
    Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan’s suspension of its HPV vaccine recommendation. Hum Vaccin Immunother. 2014;10:2543–50.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, et al. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Report Systems. Immunol Res. 2015;61:90–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Martinez-Lavin M. Fibromyalgia-like illness in 2 girls after human papillomavirus vaccination. J Clin Rheumatol. 2014;20:392–3.CrossRefPubMedGoogle Scholar
  8. 8.
    Danish Health and Medicines Authority. Danish Pharmacovigilance Update, 29 Jan 2014 [Internet] [cited 2014 Nov 15]. http://sundhedsstyrelsen.dk/en/news/2014/~/media/0540230CC7344D6589018F88BB171F51.ashx.
  9. 9.
    Hotta O. Chronic epipharyngitis and its possible focal-infection role. Stomato-pharyngol. 2013;23:37–42.Google Scholar
  10. 10.
    Neumann H, Fujishiro M, Wilcox CM, Mönkemüllerx K. Present and future perspectives of virtual chromoendoscopy with i-scan and optical enhancement technology. Dig Endosc. 2014;26(Suppl 1):43–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Hotta O, Tanaka A, Tani S. Epipharyngeal treatment in systemic disease: anticipated breakthrough. Stomato-pharyngol. 2016;29:99–106.Google Scholar
  12. 12.
    Kaneko T, Mii A, Fukui M, Nagahama K, Shimizu A, Tsuruoka S. IgA nephropathy and psoriatic arthritis that improved with steroid pulse therapy and mizoribine in combination with treatment for chronic tonsillitis and epipharyngitis. Intern Med. 2015;54:1085–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34:258–65.CrossRefGoogle Scholar
  14. 14.
    Farhat SC, Silva CA, Orione MA, Campos LM, Sallum AM, Braga AL. Air pollution in autoimmune rheumatic diseases: a review. Autoimmun Rev. 2011;11:14–21.CrossRefPubMedGoogle Scholar
  15. 15.
    Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ, et al. Smoke and autoimmunity: the fire behind the disease. Autoimmun Rev. 2016. doi: 10.1016/j.autrev.2016.01.001.Google Scholar
  16. 16.
    Hotta O, Tanaka A, Torigoe A, Imai K, Ieiri N. Chronic fatigue syndrome following human papilloma virus vaccination: is chronic epipharyngitis to blame? Isr Med Assoc J. (in press).Google Scholar
  17. 17.
    Agmon-Levin N, Zafrir Y, Kivity S, Balofsky A, Amital H, Shoenfeld Y. Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA). Immunol Res. 2014;60:376–83.CrossRefPubMedGoogle Scholar
  18. 18.
    Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Löwe B. Toward positive diagnosis criteria: a systemic review of somatoform disorder diagnoses and suggestions for future classification. J Psycosom Res. 2010;68:403–14.CrossRefGoogle Scholar
  19. 19.
    Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y. Sjögren’s syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmun. 2014;51:10–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Poddighe D, Castelli L, Marseglia GL, Bruni P. A sudden onset of pseudo-neurological syndrome after HPV-16/18 AS04-ajuvanted vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder? Immunol Res. 2014;60:236–46.CrossRefPubMedGoogle Scholar
  22. 22.
    Agmon-Levin N, Arango MT, Kivity S, Katzav A, Gilburd B, Blank M, et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in murine model. J Autoimmun. 2014;54:21–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Papadopoulos AS, Cleare AJ. Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2011;8:22–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress. 2007;10:13–25.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Osamu Hotta
    • 1
  • Ayaki Tanaka
    • 2
  • Akira Torigoe
    • 1
  • Kazuaki Imai
    • 3
  • Norio Ieiri
    • 1
  • on behalf of the Japanese Focal Inflammation Research Group
  1. 1.Division of Internal MedicineHotta Osamu ClinicSendaiJapan
  2. 2.Tanaka ENT ClinicOsakaJapan
  3. 3.Mirai ClinicFukuokaJapan

Personalised recommendations